Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. V.PDA


Primary Symbol: VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

Bullboard Posts
Comment by Goalkeeper1on Jul 06, 2018 3:56pm
279 Views
Post# 28279557

RE:1 minute video...MUST WATCH

RE:1 minute video...MUST WATCH1. Production Capacity and Capability
• 2018 capacity – 800 kilograms of indoor grown premium dry flower and 1,500 kilograms of  
seasonal greenhouse cannabis  
• 2019 capacity – 1,500 kilograms of indoor grown premium bud and 14,000 kilograms of seasonal  
greenhouse cannabis to be used primarily in finished medical and adult-use products
Targeted for completion in late Q3 2018, the Company’s Vanluven expansion includes state-of-the-art  
areas for cultivation, extraction, formulation and packaging. ABcann is expecting to receive GMP  
certification in late Q4 2018 or early Q1 2019, facilitating the export of products to certain international
markets.
The Company is developing a plan for the construction of its Kimmett facility. The macro plan and budget  
for the facility are not expected to be completed until later this year, however the Company has developed
the following three-phased approach to begin to generate revenue from the facility prior to its  
completion:
• Phase 1, which has recently commenced, consists of the construction of seasonal greenhouses
and a header house with an annual production capacity of approximately 4,000 kilograms. Subject  
to receipt of necessary Health Canada approvals, this innovative design is expected to result in  
one of the lowest capital and operating costs per gram in the industry. It is estimated that cannabisproduced from these seasonal greenhouses will be produced for less than $0.50 per gram.
Bullboard Posts